Member Comments are provided by individuals and reflect their personal opinions only. Under NO circumstances should you act on any advice or opinion posted in this forum. ALWAYS check with your personal physician before taking any action regarding your health! MedHelp International and our partners, sponsors and affiliates have no obligation to monitor any comments posted on this site, or the content and/or accuracy of such exchanges. MedHelp International does not endorse the views of any user.
The density of the estrogen receptors are the ones being reported when being tested. This eliminates the traditional reporting of just estrogen receptor positive or negative. A value of 10 means that you have enough estrogen receptor density that can make the tumor responsive to hormonal therapy (tamoxifen for premenopausal or aromatase inhibitors for post menopausal), and decrease the chance of recurrence. If you have ceased menses during chemo, then it may be an option for you to ascertain your menopausal status through testing for estradiol, FSH, and LH levels. If these levels are postmenopausal in values (they have cut-off levels), then you may derive more benefit from aromatase inhibitors (letrozole, anastrozole, or exemestane) compared with tamoxifen. I suggest you discuss all of these options with your oncologist. Regards and God bless.
The density of the estrogen receptors are the ones being reported when being tested. This eliminates the traditional reporting of just estrogen receptor positive or negative. A value of 10 means that you have enough estrogen receptor density that can make the tumor responsive to hormonal therapy (tamoxifen for premenopausal or aromatase inhibitors for post menopausal), and decrease the chance of recurrence. If you have ceased menses during chemo, then it may be an option for you to ascertain your menopausal status through testing for estradiol, FSH, and LH levels. If these levels are postmenopausal in values (they have cut-off levels), then you may derive more benefit from aromatase inhibitors (letrozole, anastrozole, or exemestane) compared with tamoxifen. I suggest you discuss all of these options with your oncologist. Regards and God bless.